Stock Spotlight: THG founder gives up golden share as takeover questions loom

Stock price fallen 89.4% since peak

Elliot Gulliver-Needham
clock • 4 min read

THG, formerly known as the Hut Group, has seen its stock price shoot up amid rumours of a buyout and founder Matt Moulding’s revoking of his ‘golden share’, which allowed him to block any attempt to takeover the company

The firm's stock price has fallen 89.4% since its peak in January 2021, according to data from MarketWatch, which occurred only months after its float in September 2020. Victoria Scholar, head of investment at interactive investor, explained there had been a number of high-profile listing "disasters", such as THG, which she said had specifically struggled with "disappointing financial results, corporate governance issues and the abandonment of its agreement with investor Softbank". Kelso Group increases its stake in THG amid takeover rumours However, the firm is up 80.6% year-t...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot